Agenda item: 5 EAST AND NORTH HERTFORDSHIRE NHS TRUST

Similar documents
EAST AND NORTH HERTFORDSHIRE NHS TRUST

EAST AND NORTH HERTFORDSHIRE NHS TRUST

EAST AND NORTH HERTFORDSHIRE NHS TRUST

EAST AND NORTH HERTFORDSHIRE NHS TRUST CHIEF EXECUTIVE S REPORT

Supporting all NHS Trusts to achieve NHS Foundation Trust status by April Ipswich Hospital NHS Trust NHS East of England Department of Health

Quality Accounts: Corroborative Statements from Commissioning Groups. Nottingham NHS Treatment Centre - Corroborative Statement

PATIENT SAFETY, QUALITY & RISK COMMITTEE

NHS East and North Hertfordshire Clinical Commissioning Group. Quality Committee. Terms of Reference Version 4.0

WOLVERHAMPTON CLINICAL COMMISSIONING GROUP QUALITY & SAFETY COMMITTEE

TRUST BOARD SEPTEMBER Surgical Services Reconfiguration

SUPPORTING PLANNING 2013/14 FOR CLINICAL COMMISSIONING GROUPs

The operating framework for. the NHS in England 2009/10. Background

Welcome, Apologies for Absence and Declaration of Board Members Interest

HERTFORDSHIRE COMMUNITY HEALTH SERVICES

QUALITY COMMITTEE. Terms of Reference

Associate Director of Patient Safety and Quality on behalf of the Director of Nursing and Clinical Governance

Trust Board Meeting: Wednesday 13 May 2015 TB

Quality, Safety & Experience (QSE) Committee. Minutes of the Meeting Held on Wednesday 29 th March 2017 in the Boardroom, Carlton Court, St Asaph

Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care.

Integrated Performance Report

Supporting all NHS Trusts to achieve NHS Foundation Trust status by April 2014

EMBEDDING A PATIENT SAFETY CULTURE

CCG Annual General Meeting (AGM) AGENDA Thursday 19 July 2018, 17:30hrs to 19:00hrs

Agenda Item 5.1 Appendix 11 CWM TAF UNIVERSITY LOCAL HEALTH BOARD

Learning from Deaths Policy

NHS England (London) Assurance of the BEH Clinical Strategy

Learning from Deaths Policy

Warrington CCG Operational Safeguarding Children Health Forum. Terms of Reference

Implementation of the right to access services within maximum waiting times

Agenda Item number: 9.1. Maggie Bayley, Director of Nursing and Quality

North Cumbria University Hospitals NHS Trust Proposed Acquisition by a Foundation Trust. Stakeholder Event Wednesday, 12 October 2011

The safety of every patient we care for is our number one priority

CLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final

Healthcare Governance Committee Monday 5 June 2017 at 9.30am Room 2, Training Centre, Ayrshire Central Hospital

Integrated Performance Committee Assurance Reports, January 2016 and December 2015 Crishni Waring, Chair, IPC Committee

2. This year the LDP has three elements, which are underpinned by finance and workforce planning.

Item E1 - Bart s Health Quality Indicators

21 March NHS Providers ON THE DAY BRIEFING Page 1

Capacity Plan. incorporating the Resourcing Escalatory Action Plan. (copy for external circulation)

Above and beyond the call of duty

BARTS AND THE LONDON NHS TRUST TRUST BOARD MEETING

Towards a Framework for Post-registration Nursing Careers. consultation response report

NLG(13)250. DATE 30 July Trust Board of Directors Part A. Dr Liz Scott, Medical Director REPORT FROM

Meeting of Governing Body

Quality and Governance Committee. Terms of Reference

Revisions Version Date Section Reason for Change Approved by. Procedure Obsolete Date Reason Approved by

NHS Bradford Districts CCG Commissioning Intentions 2016/17

Explanatory Memorandum to the Domiciliary Care Agencies (Wales) (Amendments) Regulations 2013

Kingston Clinical Commissioning Group Report Summary

CLINICAL GOVERNANCE AND QUALITY COMMITTEE Terms of Reference

ESHT Our ambition to be outstanding by 2020

NHS Wales Delivery Framework 2011/12 1

QUALITY COMMITTEE. Terms of Reference

PUBLIC SERVICES OMBUDSMAN WALES PROGRESS WITH CORRECTIVE ACTION PLANS. Assistant Director of Patient Safety & Quality

Internal Audit. Healthcare Governance. October 2015

Lincolnshire County Council: Councillors Mrs W Bowkett, R L Foulkes, C R Oxby and N H Pepper

WELSH AMBULANCE SERVICES NHS TRUST

(Committee Chair) Chair) Interim Board Secretary (MHSA/16/25 onwards) Head of CAMHS and Childrens Learning Disability (MHSA/16/24 only)

Learning from Deaths Policy

BSUH INTEGRATED PERFORMANCE REPORT. 1) Responsive Domain 2) Safe Domain 3) Effective Domain 4) Caring Domain 5) Well Led Domain

Item No. 9. Meeting Date Wednesday 6 th December Glasgow City Integration Joint Board Finance and Audit Committee

NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12. Date of Meeting: 23 rd March 2018 TITLE OF REPORT:

20.0 Date and time of next meeting: 9.30 a.m. on 24 January 2013, The Board Room, RJAH Orthopaedic Hospital NHS Foundation Trust, Oswestry

MEETING NOTES. Minutes taking: Paola Brolis, Admin Support Manager NHS England

Staffordshire and Stoke on Trent Partnership NHS Trust. Operational Plan

NHS England London Southside 4th Floor 105 Victoria Street London SW1E 6QT. 24 th July Dear Daniel, Fiona and Louise. Re: CCG Annual Assurance

Governance and Quality Committee Review. Wendy Pugh Director of Operations and Nursing. Innovation Tom Jinks - Governance Manager.

SOUTHPORT & ORMSKIRK HOSPITAL NHS TRUST MARKETING & COMMUNICATIONS ACTION PLAN

TRUST BOARD MEETING 24 JULY 2013 PERFORMANCE REPORT MONTH 3 DIRECTOR OF OPERATIONS DIRECTOR OF OPERATIONS DIRECTOR OF OPERATIONS

The Royal Wolverhampton Hospitals NHS Trust

Prevention and control of healthcare-associated infections

Quality and Patient Safety Meeting Part 1 9 th October :30pm 3:00pm Thurrock Civic Offices. GP Board Member and Safeguarding Lead

Agenda Item number: 8.1 Enclosure: 3. Discussion. Date reviewed. 22 nd September

NHS England (South) Surge Management Framework

BOARD PAPER - NHS ENGLAND

APPENDIX 7C BENEFITS REALISATION PLAN

Policy on Learning from Deaths

abc INFECTION CONTROL STRATEGY

We plan. We achieve.

SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST Trust Key Performance Indicators May Regular report to Trust Board

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST CHIEF EXECUTIVE S REPORT. BOARD OF DIRECTORS 21 st March 2012

Independent Mental Health Advocacy. Guidance for Commissioners

CARERS POLICY. All Associate Director of Patient Experience. Patient & Carers Experience Committee & Trust Management Committee

Present: Dr Stephen Bentley Specialist Doctor Assistant Director Integrated Commissioning Associate Director Health Services Commissioning

NHS CHOICES COMPLAINTS POLICY

RBCH Actions to meet CQC Essential Standards

Serious Incident Report Public Board Meeting 26 November 2015

City of Lincoln Council. Lincolnshire County Council North Kesteven District Council

Adverse Weather / Staff Attendance During Extreme Weather Conditions. Policy and Procedure

Norfolk and Suffolk NHS Foundation Trust mental health services in Norfolk

1. This letter summarises the mairi points discussed and actions arising from the Annual Review and associated meetings in Glasgow on 20 August.

NHS Portsmouth CCG 2013/14 Contract Agreements Summary. Michelle Spandley Deputy Chief Finance Officer May Improving health services

Our Achievements. CQC Inspection 2016

Sheffield Clinical Commissioning Group

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE TRUST BOARD HELD ON 18 NOVEMBER 2015

Organisational factors that influence waiting times in emergency departments

Job Title: Head of Patient &Public Engagement and Patient Services Directorate: Corporate Affairs Department: Patient and Public Engagement

Defining the Boundaries between NHS and Private Healthcare. MECCG Policy Reference: MECCG142

NHS Herts Valleys Clinical Commissioning Group Board Meeting 14 April 2016

Jessica Dahlstrom, Head of Governance Sofia Bernsand, Deputy Head of Governance

Transcription:

Agenda item: 5 EAST AND NORTH HERTFORDSHIRE NHS TRUST Minutes of the Trust Board meeting held in public on Wednesday 25 th February 2009 at 2.00 pm in Rooms 2 and 3 at Hertford County Hospital DRAFT Present: Mr Richard Beazley Chairman Mrs Alison Murray Vice Chairman Mr Nick Carver Chief Executive Mrs Alison Bexfield Mr Stephen Brooker Mr Neil Dardis Director of Operations Mr Michael Gibbons Ms Sue Greenslade Director of Nursing & Clinical Governance Mrs Wendy Hull Director of Finance Mr Ian Morfett Mr James Quinn Medical Director In attendance: Mr Stephen Posey Mr John Webster Mrs Jinjer Kandola Mrs Victoria Fisher Ms Grace Norman Mrs Heather Schulz Mr Peter Gibson External Attendees: Mrs Liz Conder Ms Emma Black Mr Graeme Jones Director of Strategic Development Director of Corporate Development Deputy Director of HR Trust Secretary Board Committee Secretary Board Committee Secretary Head of Public Affairs Patients Panel GlaxoSmithKline NHS East of England 09/30 CHAIRMAN S OPENING REMARKS ACTION 09/30.1 The Chairman apologised for the meeting start time being delayed and explained that this was due to the Trust Board undertaking mandatory fire training. The Chairman thanked the Fire Risk Manager, on behalf of the Board. 09/30.2 The Chairman assured the public that any decisions made in the private session of the meeting, because of their commercially sensitive nature, would accurately reflect the strategies and decisions already taken in public. 09/31 DECLARATION OF INTERESTS There were no declarations of interest relevant to the agenda or to any potential conflict of interest. 09/32 QUESTIONS FROM THE PUBLIC There were no questions from members of the public. 09/33 APOLOGIES FOR ABSENCE 1

Apologies were received from Ms Janet Lynch, Director of HR and OD, who was represented by Mrs Jinjer Kandola, Deputy Director of HR. 09/34 MINUTES OF THE PREVIOUS MEETING The Board approved the minutes as an accurate record of the meeting of 28 th January 2009. 09/35 MATTERS ARISING The Board was satisfied that all actions were completed or were on track. 09/36 CHIEF EXECUTIVE S REPORT 09/36.1 The Board reviewed the Chief Executive s monthly update on recent developments, which included the staff briefing meeting on DQHH (Delivering Quality Healthcare for Hertfordshire), a visit from the Herfordshire County Council s Overview and Scrutiny Committee at the Mount Vernon Cancer Centre and the heroic efforts made by staff to get to work during the recent adverse weather. 09/36.2 The Chairman joined the Chief Executive in thanking all the staff who made extra effort to come to work so that many services could continue without disruption. 09/36.3 The Chief Executive drew particular attention to the staff briefing meeting which had taken place on 23 rd February. There had been an encouraging attendance with over 100 staff. Additional sessions have been scheduled, both at the Lister and QEII. 09/36.4 The Chairman expressed his thanks to the PCT for their involvement. 09/37 DQHH UPDATE 09/37.1 The Board considered an update report on progress towards the consolidation of acute services under Delivering Quality Healthcare for Hertfordshire (DQHH). The report had been discussed in detail by the Finance and Performance Committee (FPC). 09/37.2 The Board noted that it would receive the Estates Strategy in March 2009. 09/37.3 The Board discussed the implications of the Maternity Services completion date being delayed by six months. It was explained that this was rooted in providing the best clinical care and patient experience, owing to the need to add a second phase. It was important to ensure that the financial implications of the delay were fully understood as well as being built into the financial model. 09/37.4 The Board noted that the first three phases of DQHH have made 2

significant progress and phase one (the Independent Sector Treatment Centre, ISTC) was at the commercial negotiation phase. The Board had spent considerable time reviewing the commercial, business and clinical issues and was likely to finalise the negotiations on the 2 nd March. This project would constitute the first of three major commitments, and which will form a significant component of DQHH. The Chairman thanked the Executive team, the PCT, the SHA and all other staff involved for their hard work in bringing the ISTC negotiations to this stage. 09/38 PATIENT SAFETY & INFECTION CONTROL 09/38.1 The Board considered a paper outlining the Trust s current performance in relation to MRSA and C. difficile, together with a number of patient safety indicators. 09/38.2 The Board was informed that there had been two cases of MRSA in February and four cases of C. difficile. The Board queried whether the increase in cases of C. difficile presented in December and January was because of seasonal variation and was informed that this was the case. The Trust remained below trajectory for the year. 09/38.3 The Board queried whether the origin of the MRSA cases could be identified and discussed with the PCT to prevent recurrences. It was informed that the Director of Nursing meets monthly with the wider health economy to discuss issues and practices. However, in the next financial year, community cases will be counted separately in order to provide more detailed information about the Trust s performance. 09/38.4 The Chairman noted that since June there had been no post 48 hour incidents which suggested that learning was now becoming fully embedded. This was a significant improvement in the care provided to patients. 09/38.5 The Board also questioned whether the MRSA and C difficile targets for the next financial year are sufficiently ambitious. The Director of Nursing confirmed that the Trust would set its own internal ambitious targets for MRSA irrespective of those set externally, in addition to reporting on the external target. 09/38.6 The HSMR (Hospital Standardised Mortality Rate) was also discussed, with the Board requesting that when the next set are of figures released, the six highest and six lowest scoring areas are reported to the Board in order to identify areas for further improvement. The Medical Director cautioned that a high HSMR score did not necessarily reflect the quality of care, but that there could be alternative explanations, such as issues with coding. Medical Director 09/38.7 Finally, the Board questioned whether there were other infections or patient safety standards which it should be monitoring more proactively, and was informed that the new CQUIN (Commissioning for Quality and Innovation) standards would become the key areas for focus. There would also be 3

new areas such as patient prophylaxis to reduce the risk of hospital acquired thrombosis. The Board asked that all these aspects be pulled together in one paper to be presented to the RAQC (Risk and Quality Committee) in the first instance. The Medical Director agreed to address this by expanding the follow up report to his Improving Patient Outcomes paper. Medical Director 09/39 COMPLIANCE & CLINICAL EFFICIENCY REPORT 09/39.1 The Board considered a report demonstrating the progress achieved against the Healthcare Commission core standards and national targets, together with exception reports on A&E, cancelled operations, delayed transfers of care and two new cancer targets (14 day cancer referral to review and 31 days from diagnosis to treatment and 62 day of referral to treatment), and a report on performance against a number of clinical efficiency indicators. 09/39.2 The Board noted that the report had been reviewed in detail by the FPC. 09/39.3 The Director of Operations explained that to date thresholds for compliance with the three new cancer targets had not been set so the Trust was currently measuring them against the old thresholds. However, the Director of Operations explained that the reason the thresholds are likely to be lower to account for a proportion of patients choosing not to accept an appointment. 09/39.4 The Board noted that the lack of community care had resulted in a large number of beds being blocked in January which had an impact on the A&E and cancelled operations targets. 09/39.5 The Chairman articulated the Board s concern that the Trust was not achieving compliance on standards where the control lay with another organisation. Specifically, the thrombolysis target was not being met because the Ambulance Trust was unable to meet their part of the target; therefore up to 15% of beds were blocked by patients who should have been referred to community care. 09/39.6 The Board noted that the clinical efficiency paper had been under development, and both the FPC and Board would now be receiving a shorter paper. The Board asked that this should provide some analysis on the standards and identify the areas of difficulty on an exception basis so that it could assess the wider strategic issues. The Board noted that achieving upper quartile performance linked to a strategy for organisational development that would be presented in the next two to three months. Director of Operations 09/40 FINANCE AND PERFORMANCE COMMITTEE REPORT The Board noted the issues raised by the FPC the detail of which was considered in the following agenda item. The FPC emphasised the need for cross cutting initiatives to improve a number of processes. 09/41 FINANCE REPORT AT MONTH 10 4

09/41.1 The Board considered a report setting out the Trust s financial position at the end of Month 10 compared with plan, together with a number of technical annexes. The paper had been discussed in detail by the FPC. 09/41.2 Income recovery had improved in January, at 0.2m over plan, and spending has been maintained in line with the plan. Reserves had been issued as planned and the Trust had confidence of delivering a year end surplus of 2m baring exceptional circumstances. 09/41.3 The Board questioned whether the 2m surplus was contingent on achieving stringent CIPs and was informed that these would further protect the position but are not crucial. 09/41.4 The Board also queried what impact the snow in February would have had on the financial position. The Director of Finance explained that there had been little unexpected use of bank staff, and few staff had been unable to come in to work, many making significant efforts. The Chairman, on behalf of the Board, thanked all staff for their efforts to come in despite the adverse weather. 09/41.5 The Chairman noted that the Board was receiving a great deal of information about the financial position and asked for a review of the appropriate level of detail to be undertaken. It was agreed that this would be reviewed by the FPC in conjunction with the new Director of Finance. 09/41.6 The Board questioned the workforce data and was informed that currently as many staff members were leaving the Trust as joining. Nursing staff, in particular, were under establishment by 250 whole time equivalents. Retention was the key and the Board asked to be provided with the detail of the succession planning policy to address this. Director of HR & OD 09/42 NOLAN PRINCIPLES 09/42.1 The Board was asked to adopt the Nolan principles formally and to support their wide dissemination throughout the Trust. Trust Secretary 09/42.2 The Board unanimously passed a vote in favour of adopting the principles. 09/43 REPORT FROM THE FOUNDATION TRUST COMMITTEE The Board noted the report from the Foundation Trust Committee. The Director of Corporate Development requested that all members attend the next meeting since the Trust s strategy as reflected in IBP would be the main agenda item. 09/44 REPORT FROM THE RISK AND QUALITY COMMITTEE 09/44.1 The Board noted the issues escalated by the RAQC. 09/44.2 The Board noted the interconnection of a number of the issues, 5

such as problems of medical records and an increase in complaints. This highlighted the need for Trust wide crosscutting initiatives and measurable outcomes to improve productivity and efficiency, as previously discussed. 09/45 ANY OTHER BUSINESS There being no further business, the Chairman proposed that the Board move into private session at 3.30pm. 09/46 DATE OF NEXT MEETING The next Board meeting would be held on Wednesday 25 th March 2009 at 2.00pm at the Lister Education Centre`. Richard Beazley Chairman 6